百晓学者学者目录

朱波

副教授、博士生导师、博导、教授、研究员、讲师，重庆医科大学

精选作品

期刊论文

2026

生物物理信号调控抗肿瘤免疫反应的机制及其在免疫治疗中的应用

毛涛，吴玉翠，陈德高，朱波

《中国肿瘤生物治疗杂志》

2026

Role of the Gut-brain Axis in the Cancer-immunity Cycle

Yulun Wu, Tao Jiang, Bo Zhu, Hui Jun Zhou

Genomics Proteomics & Bioinformatics

DOI

2026

Tumor-derived DNA drives cancer-associated anemia by promoting reticulocyte clearance

Ting Yuan, Xuebing Liu, Yucui Wu, Shanshan Li, Han Chu, Qing Li, Zefang Chen, Haichuan Liu, Tao Mao, Haoran Zha, Xiaoming Cheng, Jing Jing, Chengmu Li, Lina Peng, Xiaoxing Chen, Qian Liao, Renren Yu, Hao Lv, Junwei Zhang, Zhongyu Wang, Qingzhu Jia, Haixia Long, Degao Chen, Bo Zhu

Signal Transduction and Targeted Therapy

DOI

2025

Tame the Hydra’s head: Targeting bone marrow maladaptive myelopoiesis to reverse macrophage-mediated immunosuppression in cancer

Zheng Jin, Bo Zhu

Immunity

DOI

2025

S100A8/A9 perturbation in bone marrow blunts antitumor immunity by promoting protumorigenic myelopoiesis in mouse models

Wen Luo, Xingxing Su, Qiao Zhang, Zhongyu Wang, Jin Zheng, Yanan Li, Yang Fei, Dong Zeng, Xianghua Zeng, Guitong Lv, Mengyi Li, Jiani Huang, Haoran Zha, Ji Liu, Zhong Yuan Luo, Haixia Long, Bo Zhu

Science Translational Medicine

DOI

2025

Bone metastases diminish extraosseous response to checkpoint blockade immunotherapy through osteopontin-producing osteoclasts

Jianan Cheng, Zheng Jin, Chunxia Su, Tao Jiang, Xiaobin Zheng, Jinming Guo, Xingyi Li, Han Chu, Jia Jia, Qin Zhou, Xiaofang Ding, Yiwen Zhang, Shouxia Xu, Fancong Dong, Qiao Zhang, Xinxin Yang, Tao Yang, Xiaoming Cheng, Haoran Zha, Degao Chen, Yisong Y. Wan, Xindong Liu, Lilin Ye, Haidong Tang, Alistair L. J. Symonds, Qi-Jing Li, Qingzhu Jia, Bo Zhu

Cancer Cell

DOI

2024

小鼠GSDME对肿瘤进展的抑制作用及其机制

陈德高，余忍忍，吴玉翠，边阳萍，吕浩，袁婷，朱波

《免疫学杂志》

2024

肿瘤患者免疫检查点抑制剂相关性肺炎的特征及临床结局分析

杨琰，白华，肖文文，朱波，王中瑜

《陆军军医大学学报》

2023

CHIT1作为免疫治疗长生存生物标志物的研究

吕浩，袁婷，金铮，贾罄竹，陈德高，朱波

《免疫学杂志》

2023

肿瘤免疫治疗耐药机制与克服策略

朱波

《中国肿瘤生物治疗杂志》

2023

CD200+ cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti–PD-1/PD-L1 therapy

Xinxin Wang, H. Zha, Wei Wu, T. Yuan, Shuanglong Xie, Zheng Jin, H. Long, Fei Yang, Zhongyu Wang, Anmei Zhang, Jianbao Gao, Ying Jiang, Lu-Jing Wang, Chun-Yan Hu, Y. Wan, Qi-Jing Li, A. Symonds, Q. Jia, Bo Zhu

Science Translational Medicine

DOI

2023

Caspase-8 contributes to an immuno-hot microenvironment by promoting phagocytosis via an ecto-calreticulin-dependent mechanism

Z. Gong, Q. Jia, Jin-Ming Guo, Chongyi Li, Shouxia Xu, Zheng Jin, Han Chu, Y. Wan, Bo Zhu, Yi Zhou

Experimental Hematology & Oncology

DOI

2023

Tumor-specific memory CD8+ T cells are strictly resident in draining lymph nodes during tumorigenesis

Qiao-Yi Liu, Ling Ran, Zhengliang Yue, Xing-Xing Su, Lisha Wang, Shuqiong Wen, Shun Lei, Xiaofan Yang, Yan Zhang, Jianjun Hu, Jian-Fang Tang, Zhi-Rong Li, Li Hu, Bo Zhu, Li-Fan Xu, L. Ye, Qi-Zhao Huang

Cellular & Molecular Immunology

DOI

2023

Chromothripsis is correlated with reduced cytotoxic immune infiltration and diminished responsiveness to checkpoint blockade immunotherapy

Han Chu, Zheng Jin, Jia-Nan Cheng, Q. Jia, Bo Zhu, Haoyang Cai

Theranostics

DOI

2023

EBV-upregulated B7-H3 inhibits NK cell-mediated antitumor function and contributes to nasopharyngeal carcinoma progression.

Haiwen Chen, Xiaobing Duan, Xiao-Hong Deng, Ying Huang, Xiang Zhou, Shanshan Zhang, Xiao Zhang, Pingjuan Liu, Chao-Pin Yang, Guojun Liu, Qinqin Ren, Yan Xiong, Bo Zhu, Jie-Xia Zhang, T. Xiang

Cancer immunology research

DOI

2023

Author Correction: Tumor-specific memory CD8+ T cells are strictly resident in draining lymph nodes during tumorigenesis

Qiao-Yi Liu, Ling Ran, Zhengliang Yue, Xing-Xing Su, Lisha Wang, Shuqiong Wen, Shun Lei, Xiaofan Yang, Yan Zhang, Jianjun Hu, Jian-Fang Tang, Zhi-Rong Li, Li Hu, Bo Zhu, Li-Fan Xu, L. Ye, Qi-Zhao Huang

Cellular & Molecular Immunology

DOI

2023

TCR-T cells armored with immune checkpoint blockade in EBV-positive nasopharyngeal carcinoma: The first-in-human phase 1/2 trial.

Q. Jia, Ling Peng, Gang Chen, Haiyang Wu, D. Zeng, Tao Liu, Y. Zhan, Si Li, Frank Su, Bo Zhu, Qi-Jing Li

Journal of Clinical Oncology

DOI

2023

Tumor-associated myeloid cells in cancer immunotherapy

Xin-Yu Cheng, Huilan Wang, Zhongyu Wang, Bo Zhu, H. Long

Journal of Hematology & Oncology

DOI

2023

Synergistic immunotherapy targeting cancer-associated anemia: prospects of a combination strategy

Ting Yuan, Q. Jia, Bo Zhu, Degao Chen, H. Long

Cell Communication and Signaling

DOI

2022

Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy.

H. Long, Q. Jia, Liuyang Wang, W. Fang, Zhongyu Wang, Tao Jiang, Fei Zhou, Zheng Jin, Jia-Ni Huang, Li Zhou, Chunyan Hu, Xinxin Wang, Jin Zhang, Yujie Ba, Yujie Gong, Xiang-Hua Zeng, D. Zeng, Xing-Xing Su, Peter B. Alexander, Li Wang, Limei Wang, Y. Wan, Xiao-Fan Wang, Li Zhang, Qi-Jing Li, Bo Zhu

Cancer Cell

DOI

2022

Neoantigens in precision cancer immunotherapy: from identification to clinical applications

Qiao-Ling Zhang, Q. Jia, Jing Zhang, Bo Zhu

Chinese Medical Journal

DOI

2022

Differential expression of inhibitory receptor NKG2A distinguishes disease‐specific exhausted CD8+ T cells

Xiang-Yu Chen, Yao Lin, S. Yue, Yang Yang, Xinxin Wang, Z. Pan, Xiaofan Yang, Lei-Qiong Gao, Jing Zhou, Zhi-Rong Li, Li Hu, Jian-Fang Tang, Qing Wu, Yi-Fei Wang, Qin Tian, Ya-Xing Hao, Li-Fan Xu, Bo Zhu, Qi-Zhao Huang, L. Ye

MedComm

DOI

2022

High-throughput single-сell sequencing in cancer research

Q. Jia, Han Chu, Zheng Jin, H. Long, Bo Zhu

Signal Transduction and Targeted Therapy

DOI

2022

Modulating Tumor Physical Microenvironment for Fueling CAR-T Cell Therapy.

Zhong Luo, Xuemei Yao, Meng-Huan Li, De-xin Fang, Yang Fei, Zhuo Cheng, Ying-Ying Xu, Bo Zhu

Advanced Drug Delivery Reviews

DOI

2022

Type I interferon-mediated tumor immunity and its role in immunotherapy

Renren Yu, Bo Zhu, Degao Chen

Cellular and Molecular Life Sciences

DOI

2022

Heterogeneity of the tumor immune microenvironment and its clinical relevance

Q. Jia, Aoyun Wang, Yixiao Yuan, Bo Zhu, H. Long

Experimental Hematology & Oncology

DOI

2021

S100A8作为非小细胞肺癌免疫检查点抑制剂治疗疗效预测指标的研究

苏星星，金铮，贾罄竹，朱波，龙海霞

《免疫学杂志》

2021

循环肿瘤DNA在晚期肿瘤免疫治疗中的预后及预测作用

朱波，卢红莲

《循证医学》

2021

Non-canonical PD-1 signaling in cancer and its potential implications in clinic

H. Zha, Ying Jiang, Xi Wang, Jin Shang, Ning Wang, Lei Yu, Wei Zhao, Zhi-Hua Li, Juan An, Xiaochun Zhang, Huo-ming Chen, Bo Zhu, Zhao-Xia Li

Journal for ImmunoTherapy of Cancer

DOI

2021

Impact of Dissected Lymph Node Count on PD-1 Inhibitors Efficacy in Postoperative Recurred NSCLC: A Multi-Institutional Retrospective Study

C. Su, H. Deng, Juan Zhou, Hualin Chen, Xiuyu Cai, R. Zhong, Feng Li, B. Cheng, Cai-Chen Li, Q. Jia, Cai-Cun Zhou, Jian-Xing He, R. Peterson, G. Rocco, A. Brunelli, C. Ng, T. D'Amico, W. Liang, Bo Zhu

Social Science Research Network

DOI

2021

Myeloid-Derived Suppressor Cells: A Multifaceted Accomplice in Tumor Progression

Jia-Nan Cheng, Yifang Yuan, Bo Zhu, Q. Jia

Frontiers in Cell and Developmental Biology

DOI

2021

Titin mutation in circulatory tumor DNA is associated with efficacy to immune checkpoint blockade in advanced non-small cell lung cancer

C. Su, Xinxin Wang, Juan Zhou, Jing‐ya Zhao, Fei Zhou, Guo-Dong Zhao, Xiao-Hong Xu, X. Zou, Bo Zhu, Q. Jia

Translational Lung Cancer Research

DOI

2021

ENPEP as a potential predictor of immune checkpoint inhibitor efficacy

Aoyun Wang, Han Chu, Zheng Jin, Z. Gong, Q. Jia, Bo Zhu

Cancer Medicine

DOI

2021

Embryonic Origin and Subclonal Evolution of Tumor-Associated Macrophages Imply Preventive Care for Cancer

Xiao-Mei Zhang, Degao Chen, S. Li, Bo Zhu, Zhong-Jun Li

Cells

DOI

2021

Stereotactic Body Radiotherapy Is Effective in Modifying the Tumor Genome and Tumor Immune Microenvironment in Non-Small Cell Lung Cancer or Lung Metastatic Carcinoma

Pu Zhou, Dian-gang Chen, Bo Zhu, Wei Chen, Qichao Xie, Ya-Li Wang, Qiu-lin Tan, Bi-Bo Yuan, Xuejiao Zuo, Chang-Ling Huang, Hongfan Zhu, Guanghui Li

Frontiers in Immunology

DOI

2021

Radiation-induced eosinophils improve cytotoxic T lymphocyte recruitment and response to immunotherapy

Jia-Nan Cheng, Wen Luo, Chengdu Sun, Zheng Jin, Xiang-Hua Zeng, Peter B. Alexander, Z. Gong, Xin Xia, Xiao-Fan Ding, Shouxia Xu, P. Zou, Y. Wan, Q. Jia, Qi-Jing Li, Bo Zhu

Science Advances

DOI

2021

Mutational burden and chromosomal aneuploidy synergistically predict survival from radiotherapy in non-small cell lung cancer

Q. Jia, Q. Chu, Anmei Zhang, Jing Yu, Fang-Fang Liu, Kai-Yu Qian, Yu Xiao, Xue Wang, Ying Yang, Yi Zhao, Ji He, Guanghui Li, Y. Wan, C. Xie, Bo Zhu

Communications Biology

DOI

2021

Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma

Q. Jia, Diyuan Qin, Feng He, Qichao Xie, Z. Ying, Ya-Jing Zhang, Yu-Qin Song, Jia-Nan Cheng, Xuejiao Zuo, Lu-Xiang Xu, Hong-Liang Fang, Chunyan Hu, Li-Na Peng, Tao Jin, Zi-Xiao Shi, Peter B. Alexander, Yong-Sheng Wang, Yarong Liu, Weidong Han, Jun Zhu, Pin Wang, Qi-Jing Li, Bo Zhu

Theranostics

DOI

2021

Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages

Degao Chen, Xiao-Mei Zhang, Zhong-Jun Li, Bo Zhu

Theranostics

DOI

2021

Fusion of Invasive Tumor Cells with Infiltrating Macrophages Fuels Epithelial-Mesenchymal Transition and Adaptive Immune Evasion

Xiao-feng Han, Bo Zhu, Xue-Mei Zhang, Jing Luo, Hui Chen, Yun-ping Hu, Faith Liu, Christine Brown, Amy Burnside, Guohui Fu, Fa-Xue Zhao, Hong-Zhuan Chen, Denise Oh, L. Schwartz, Yingbin Liu, R. Shao

DOI

2021

Programmed Cell Death Protein Ligand 2 Is a Potential Biomarker That Predicts the Efficacy of Immunotherapy

Aoyun Wang, Han Chu, Zheng Jin, Q. Jia, Bo Zhu

Disease Markers

DOI

2020

中国非小细胞肺癌免疫检查点抑制剂治疗专家共识（2019年版）

周彩存，王洁，步宏，王宝成，韩宝惠，卢铀，王哲海，朱波，王子平，宋启斌，任胜祥，林冬梅，何雅億，胡晓桦，赵洪云，秦叔逵

《中国肺癌杂志》

2020

Neoantigen Tracking: Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer (Adv. Sci. 9/2020)

Q. Jia, Luting Chiu, Shuang-Xiu Wu, J. Bai, Li-Na Peng, Linpeng Zheng, Rui Zang, Xue-Qin Li, Bi-Bo Yuan, Yi-Xing Gao, Dingyong Wu, Xiao-Hong Li, Lin Wu, Jian-Guo Sun, Ji He, Bruce W. S. Robinson, Bo Zhu

Advancement of science

DOI

2020

Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer

Q. Jia, Luting Chiu, Shuang-Xiu Wu, J. Bai, Li-Na Peng, Linpeng Zheng, Rui Zang, Xue-Qin Li, Bi-Bo Yuan, Yi-Xing Gao, Dingyong Wu, Xiao-Hong Li, Lin Wu, Jian-Guo Sun, Ji He, Bruce W. S. Robinson, Bo Zhu

Advancement of science

DOI

2020

The mechanisms of pathological extramedullary hematopoiesis in diseases

Xin-Xin Yang, Degao Chen, H. Long, Bo Zhu

Cellular and Molecular Life Sciences

DOI

2020

Immune subtype of mismatch repair deficient colorectal carcinoma.

N. He, Q. Jia, Ge Jin, Bo Zhu

DOI

2020

Antitumor effects of targeting myeloid-derived suppressive cells

D. Zeng, H. Long, Bo Zhu

Translational Cancer Research

DOI

2020

Effect of Comorbidity on Outcomes of Patients with Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD1 Immunotherapy

Xiang-Hua Zeng, Shi-Cong Zhu, Cheng Xu, Zhongyu Wang, Xing-Xing Su, D. Zeng, H. Long, Bo Zhu

Medical Science Monitor

DOI

2020

Gene expression profiling identified TP53MutPIK3CAWild as a potential biomarker for patients with triple-negative breast cancer treated with immune checkpoint inhibitors

Jia-Nan Cheng, Xiao-Fan Ding, Shouxia Xu, Bo Zhu, Q. Jia

Oncology Letters

DOI

2020

C3a-C3aR signaling promotes breast cancer lung metastasis via modulating carcinoma associated fibroblasts

Chi Shu, H. Zha, H. Long, Xinxin Wang, Fei Yang, Jianbao Gao, Chunyan Hu, Li Zhou, Bo Guo, Bo Zhu

Journal of experimental & clinical cancer research : CR

DOI

2019

PAPPA2突变重构炎性肿瘤微环境促进免疫检查点抑制剂治疗应答

赵月涛，龚志华，徐亮，曾祥华，朱波，贾罄竹

《免疫学杂志》

DOI

2019

Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer

Sha Zhao, S. Ren, T. Jiang, Bo Zhu, Xue-Fei Li, Chao Zhao, Yijun Jia, Jinpeng Shi, Limin Zhang, Xiao-Zhen Liu, M. Qiao, Xiaoxia Chen, C. Su, Hui Yu, Cai-Cun Zhou, Jun Zhang, D. Camidge, Fred R. Hirsch

Cancer immunology research

DOI

2019

EZH2 regulates PD-L1 expression via HIF-1α in non-small cell lung cancer cells.

Yuetao Zhao, Xin-Xin Wang, Wei Wu, H. Long, Jia-Ni Huang, Zhongyu Wang, Tao Li, Shuk-Kuen Tang, Bo Zhu, De-Gao Chen

Biochemical and Biophysical Research Communications - BBRC

DOI

2019

EZH2 Inhibitor GSK126 Suppresses Antitumor Immunity by Driving Production of Myeloid-Derived Suppressor Cells.

Shuo Huang, Zhongyu Wang, Jie Zhou, Jia-Ni Huang, Li Zhou, Jing Luo, Y. Wan, H. Long, Bo Zhu

Cancer Research

DOI

2019

Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation

Jie Zhou, Shuo Huang, Zhongyu Wang, Jia-Ni Huang, Liang Xu, Xuefeng Tang, Y. Wan, Qi-Jing Li, A. Symonds, H. Long, Bo Zhu

Nature Communications

DOI

2019

Titin mutation associated with responsiveness to checkpoint blockades in solid tumors.

Q. Jia, Jun Wang, N. He, Ji He, Bo Zhu

JCI Insight

DOI

2019

The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection

Xiang-Yu Chen, Guoshuai Cao, Jialin Wu, Xinxin Wang, Z. Pan, Jianbao Gao, Qin Tian, Li-Fan Xu, Zhi-Rong Li, Ya-Xing Hao, Qi-Zhao Huang, Pengcheng Wang, Minglu Xiao, Luoyingzi Xie, Shupei Tang, Zhenyu Liu, Li Hu, Jian-Fang Tang, Ran He, Li Wang, Xin-Yuan Zhou, Yu-Zhang Wu, Mengjie Chen, Bei-Cheng Sun, Bo Zhu, Jun Huang, L. Ye

Cellular & Molecular Immunology

DOI

2019

Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment

Yong-Sheng Li, Bo Zhu

Frontiers Research Topics

DOI

2018

贝伐珠单抗通过促进树突状细胞活化抑制光热治疗后转移瘤生长

戴颖，林翰，贾罄竹，陈雨，朱波

《医药导报》

2018

Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages

H. Zha, Xinxin Wang, Ying Zhu, Dian-gang Chen, Xiao Han, Fei Yang, Jianbao Gao, Chunyan Hu, Chi Shu, Yi Feng, Yu-Long Tan, Jin-Yu Zhang, Yong-Sheng Li, Y. Wan, Bo Guo, Bo Zhu

Cancer immunology research

DOI

2018

Immune Landscape of Colorectal Cancer Tumor Microenvironment from Different Primary Tumor Location

Long-zhen Zhang, Yuetao Zhao, Ying Dai, Jia-Nan Cheng, Z. Gong, Yi Feng, Chengdu Sun, Q. Jia, Bo Zhu

Frontiers in Immunology

DOI

2018

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer

Q. Jia, Wei Wu, Yu-Qi Wang, Peter B. Alexander, Chengdu Sun, Z. Gong, Jia-Nan Cheng, Huaibo Sun, Y. Guan, X. Xia, Ling Yang, X. Yi, Y. Wan, Haidong Wang, Ji He, P. Futreal, Qi-Jing Li, Bo Zhu

Nature Communications

DOI

2018

Abstract 5739: Targeting EZH2 histone methyltransferase activity alleviates inflammatory bowel disease

H. Long, Jie Zhou, Zhongyu Wang, Shuo Huang, Bo Zhu

Immunology

DOI

2018

Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells

Lintao Zhao, Ran He, H. Long, Bo Guo, Q. Jia, Diyuan Qin, Si-Qi Liu, Zhongyu Wang, T. Xiang, Jue Zhang, Yu-Long Tan, Jia-Ni Huang, Jun-Ying Chen, Fang Wang, Minglu Xiao, Jianbao Gao, Xin-Xin Yang, Haotao Zeng, Xinxin Wang, Chunyan Hu, Peter B. Alexander, A. Symonds, Jia Yu, Y. Wan, Qi-Jing Li, L. Ye, Bo Zhu

Nature Medicine

DOI

2018

Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19.

Yarong Liu, Bo Zhu, Q. Jia, H. Feng, Hong-Liang Fang, Jing Chen, Zi-Xiao Shi, J. Tao, B. Wei, Rong-Lin Xie, Qi-Jing Li, Pin Wang

DOI

2018

Association between angiogenesis and cytotoxic signatures in the tumor microenvironment of gastric cancer

Yi Feng, Ying Dai, Z. Gong, Jia-Nan Cheng, Long-zhen Zhang, Chengdu Sun, Xiang-Hua Zeng, Q. Jia, Bo Zhu

OncoTargets and Therapy

DOI

2018

Editorial: Metabolism of Cancer Cells and Immune Cells in the Tumor Microenvironment

Yong-Sheng Li, Bo Zhu

Frontiers in Immunology

DOI

2018

Potent immunogenicity in BRCA1‐mutated patients with high‐grade serous ovarian carcinoma

Ying Dai, Chengdu Sun, Yi Feng, Q. Jia, Bo Zhu

Journal of Cellular and Molecular Medicine

DOI

2018

Remission observed from a phase 1 clinical study of CAR-T therapy with safety switch targeting BCMA for patients with relapsed/refractory multiple myeloma.

Yarong Liu, Zhi Chen, R. Wei, L. Shi, H. Feng, Zi-Xiao Shi, J. Tao, Rong-Lin Xie, B. Wei, Jing Chen, Hong-Liang Fang, Bo Zhu, Qi-Jing Li, Pin Wang

DOI

2018

Cytotoxic chemotherapy reduces T cell trafficking to the spleen by downregulating the expression of C-C motif chemokine ligand 21 and C-C motif chemokine ligand 19

Lina Liu, Lintao Zhao, Yang Yang, Jianbao Gao, Chunyan Hu, Bo Guo, Bo Zhu

Oncology Letters

DOI

2018

Control of Intestinal Inflammation, Colitis-Associated Tumorigenesis, and Macrophage Polarization by Fibrinogen-Like Protein 2

Ying Zhu, Jie Zhou, Yi Feng, Liying Chen, Long-zhen Zhang, Fei Yang, H. Zha, Xinxin Wang, Xiao Han, Chi Shu, Y. Wan, Qi-Jing Li, Bo Guo, Bo Zhu

Frontiers in Immunology

DOI

2018

Programmed death ligand 1 expression and CD8+ tumor-infiltrating lymphocyte density differences between paired primary and brain metastatic lesions in non-small cell lung cancer.

Jie Zhou, Z. Gong, Q. Jia, Yan Wu, Zhenzhou Yang, Bo Zhu

Biochemical and Biophysical Research Communications - BBRC

DOI

2018

In Vivo Expansion and Antitumor Activity of Coinfused CD28- and 4-1BB-Engineered CAR-T Cells in Patients with B Cell Leukemia.

Zhi-Qiong Cheng, R. Wei, Qiuling Ma, Lin Shi, Feng He, Zi-Xiao Shi, Tao Jin, Rong-Lin Xie, B. Wei, Jing Chen, Hong-Liang Fang, Xiaolu Han, Jennifer A. Rohrs, P. Bryson, Yarong Liu, Qi-Jing Li, Bo Zhu, Pin Wang

Molecular Therapy

DOI

2017

Blocking C5aR signaling promotes the anti-tumor efficacy of PD-1/PD-L1 blockade

H. Zha, Xiao Han, Ying Zhu, Fei Yang, Yong-Sheng Li, Qijing Li, Bo Guo, Bo Zhu

Oncoimmunology

DOI

2017

Stroma-derived Fibrinogen-like Protein 2 Activates Cancer-associated Fibroblasts to Promote Tumor Growth in Lung Cancer

Ying Zhu, Long-zhen Zhang, H. Zha, Fei Yang, Chunyan Hu, Lin Chen, Bo Guo, Bo Zhu

International Journal on Biological Sciences

DOI

2017

Immune Cell Metabolism in Tumor Microenvironment.

Yong-Sheng Li, Y. Wan, Bo Zhu

Advances in Experimental Medicine and Biology

DOI

2017

Resolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy

Qi Zhang, Bo Zhu, Yong-Sheng Li

Frontiers in Immunology

DOI

2017

Disrupted fibroblastic reticular cells and interleukin-7 expression in tumor draining lymph nodes

Jianbao Gao, Lintao Zhao, Lina Liu, Yang Yang, Bo Guo, Bo Zhu

Oncology Letters

DOI

2017

Tumor-Derived Tissue Factor Aberrantly Activates Complement and Facilitates Lung Tumor Progression via Recruitment of Myeloid-Derived Suppressor Cells

Xiao Han, H. Zha, Fei Yang, Bo Guo, Bo Zhu

International Journal of Molecular Sciences

DOI

2016

The tumor microenvironment disarms CD8+ T lymphocyte function via a miR-26a-EZH2 axis

H. Long, T. Xiang, Jing Luo, Fei Li, R. Lin, Si-Qi Liu, Shan Jiang, Chunyan Hu, Gang Chen, Elizabeth Wong, Y. Wan, Qi-Jing Li, Bo Zhu

Oncoimmunology

DOI

2016

Interleukin‐2 reverses CD8+ T cell exhaustion in clinical malignant pleural effusion of lung cancer

Chun-Yan Hu, Youyi Zhang, T. Wang, Lihua Chen, Z. Gong, Y. Wan, Qi-Jing Li, Yafei Li, Bo Zhu

Clinical and Experimental Immunology

DOI

2016

MicroRNA-23a curbs necrosis during early T cell activation by enforcing intracellular reactive oxygen species equilibrium

Baojun Zhang, Si-Qi Liu, Chao-Ran Li, Erik A. Lykken, Shan Jiang, Elizabeth Wong, Z. Gong, Zhongfen Tao, Bo Zhu, Y. Wan, Qi-Jing Li

Immunity

DOI

2015

CAFs与肺腺癌患者临床病理特征及肿瘤浸润免疫细胞的相关性研究

成佳楠，龚志华，朱波

《免疫学杂志》

2015

EGFR-TKI down-regulates PD-L1 in EGFR mutant NSCLC through inhibiting NF-κB.

Kailong Lin, Jia-Nan Cheng, Tao Yang, Yong-Sheng Li, Bo Zhu

Biochemical and Biophysical Research Communications - BBRC

DOI

2015

C5aR, TNF-α, and FGL2 contribute to coagulation and complement activation in virus-induced fulminant hepatitis.

Jian-Jun Liu, Yu-Long Tan, Jin-Yu Zhang, L. Zou, Guohong Deng, Xueqing Xu, Feng Wang, Zhengwei Ma, Jue Zhang, Ting-ting Zhao, Yun-Lai Liu, Yong-Sheng Li, Bo Zhu, Bo Guo

Journal of Hepatology

DOI

2015

T-cell exhaustion in the tumor microenvironment

Yan Jiang, Yu Li, Bo Zhu

Cell Death and Disease

DOI

2015

Essential role of TNF-alpha in development of spleen fibroblastic reticular cells.

Lintao Zhao, Jun-Ying Chen, Lina Liu, Jianbao Gao, Bo Guo, Bo Zhu

Cellular Immunology

DOI

2015

Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy

Jianbao Gao, Lintao Zhao, Y. Wan, Bo Zhu

International Journal of Molecular Sciences

DOI

2015

miR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment

R. Lin, J. Sampson, Qi-Jing Li, Bo Zhu

Oncoimmunology

DOI

2014

肿瘤5-氟尿嘧啶治疗后可提高CD8+T细胞免疫应答

张亚辉，朱波，赵林涛

《免疫学杂志》

2014

MeCP2 enforces Foxp3 expression to promote regulatory T cells’ resilience to inflammation

Chao-Ran Li, Shan Jiang, Si-Qi Liu, Erik A. Lykken, Lintao Zhao, J. Sevilla, Bo Zhu, Qi-Jing Li

Proceedings of the National Academy of Sciences of the United States of America

DOI

2014

T lymphocytes maintain structure and function of fibroblastic reticular cells via lymphotoxin (LT)-B

Lintao Zhao, Lina Liu, Jianbao Gao, Yang Yang, Chunyan Hu, Bo Guo, Bo Zhu

BMC Immunology

DOI

2014

Tissue factor in tumor microenvironment: a systematic review

Xiao Han, Bo Guo, Yong-Sheng Li, Bo Zhu

Journal of Hematology & Oncology

DOI

2014

Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.

R. Lin, Ling Chen, Gang Chen, Chunyan Hu, Shan Jiang, J. Sevilla, Y. Wan, J. Sampson, Bo Zhu, Qi-Jing Li

Journal of Clinical Investigation

DOI

2013

PD-1+肿瘤浸润性CD8+T淋巴细胞的表型鉴定及功能研究

李小红，陈陵，朱波

《陆军军医大学学报》

2013

肿瘤环境影响抗感染CD8+T细胞应答启动的初步研究

张珏，谭雨龙，杨菲，朱波

《免疫学杂志》

2013

Targeting miR-23a in CD8+ cytotoxic T lymphocytes for tumor immunotherapy (P2072)

R. Lin, Ling Chen, Chunyan Hu, Gang Chen, Shan Jiang, J. Sevilla, Y. Wan, Bo Zhu, Qi-Jing Li

Journal of Immunology

DOI

2013

Dynamically expressed microRNA-15b modulates the activities of CD8+ T lymphocytes in mice with Lewis lung carcinoma

G. Zhong, Xiaoming Cheng, H. Long, Lu-Hang He, Wei Qi, T. Xiang, Zhong-Quan Zhao, Bo Zhu

Journal of Translational Medicine

DOI

2013

Tumor environment interferes with the priming of the anti-infection CD8~+T cell immune response in mice

Bo Zhu

2012

微小RNA调控T细胞免疫功能的研究进展

钟国成，朱波

《免疫学杂志》

2012

microRNA和T细胞发育研究进展

钟国成，李小红，朱波

《重庆医学》

2012

微小RNA调控T淋巴细胞分化的研究进展

钟国成，朱波

《中国免疫学杂志》

2012

T细胞衰竭及其分化调控机制

林凯龙，朱波

《中国免疫学杂志》

2012

Progress in regulating mechanism of miR in T cell's immune function

Bo Zhu

2011

自身抗原激活的树突状细胞联合细胞因子诱导杀伤细胞过继免疫治疗晚期前列腺癌的临床研究

闵敏，张小玉，冯怀志，陈健，孙薏，李硕，钟国成，杨帆，朱波

《中华临床医师杂志(电子版)》

2011

IL-6信号通路与肿瘤

刘徽，朱波，林治华

《细胞与分子免疫学杂志》

2011

MDSCs为靶点的肿瘤治疗策略研究进展

谢伟，朱晓春，朱波

《细胞与分子免疫学杂志》

2011

IDO基因转染小鼠树突状细胞体外诱导Treg细胞增殖的研究

谢启超，朱波，陈正堂

《重庆医学》

2011

HLA-I限制性CTL表位改造的研究进展

张恒，朱波，王远强，龙海霞，林治华

《免疫学杂志》

2010

肿瘤干细胞与肿瘤免疫

谢荣凯，龙海霞，朱波

《免疫学杂志》

2010

髓系衍生抑制性细胞与肿瘤免疫耐受

谢伟，朱波

《免疫学杂志》

2010

IL-17/IL-17R与恶性肿瘤

陈曦，朱波，陈正堂

《免疫学杂志》

2010

Cancer stem cell and tumor immunity

Bo Zhu

2009

肿瘤抗原MAGE-A亚家族共同B细胞表位预测及分析

龙海霞，万瑾，王远强，朱波，倪兵，吴玉章，林治华

《免疫学杂志》

2008

吲哚胺-2，3-双加氧酶在非小细胞肺癌中的表达及意义

谢启超，王玲俐，朱波，王亚丽，顾健滕，陈正堂

《中国肺癌杂志》

2007

IDO基因转染对小鼠Lewis肺癌细胞侵袭和转移的影响研究

谢启超，王玲俐，朱波，王亚丽，顾健滕，陈正堂

《重庆医学》

2007

IDO基因转染小鼠Lewis肺癌细胞体外诱导Treg细胞增殖的研究

谢启超，王玲俐，朱波，王亚丽，顾健滕，陈正堂

《重庆医学》

2006

树突状细胞靶向性DNA疫苗的抗肿瘤免疫效应

朱波，程晓明，段玉忠，郭波，吴玉章，陈正堂

《细胞与分子免疫学杂志》

2005

单克隆抗体在NSCLC治疗中的现状及展望

赵伟鹏，朱波，陈正堂

《中国肺癌杂志》

2005

树突状细胞靶向性DNA疫苗的构建及其在CHO细胞的表达

朱波，程晓明，郭波，吴玉章，陈正堂

《免疫学杂志》

2005

基于SCORE函数估算HLA-A*0201限制性CTL表位亲和性

朱波，林治华，陈正堂，吴玉章

《免疫学杂志》

2004

NDV-ATV治疗对非小细胞肺癌患者外周血TH极化的影响

陈芳琳，陈正堂，朱波，曹正怀

《免疫学杂志》

2004

肿瘤抗原TRAG-3 HLA-A2.1限制性CTL表位的鉴定

朱波，陈正堂，程晓明，林治华，吴玉章

《免疫学杂志》

2004

泰素耐药相关基因-3细胞毒性T淋巴细胞表位负载树突状细胞疫苗的体外免疫效应研究

朱波，陈正堂，程晓明，吴玉章

《中华肿瘤杂志》

2004

pEgr-MIP3α重组质粒的构建及其在Lewis肺癌细胞中的辐射诱导表达

邹岚，朱波，陈敬，杜剑平，陈正堂

《重庆医学》

2004

5-氮-2′-脱氧胞嘧啶诱导肺腺癌A549细胞株TRAG-3肿瘤抗原表达

朱波，陈正堂

《重庆医学》

2003

TRAG-3 HLA-A2.1限制性CTL表位的预测及结合力分析

朱波，陈正堂，程晓明，林治华，邹丽云，吴玉章

《免疫学杂志》

2001

MIP-3α吸引树突状细胞向肿瘤趋化并抑制其生长

Toshiaki Fushimi, 朱波

《国际免疫学杂志》

会议论文

2015

肿瘤免疫治疗进展与展望

朱波

《第十四届全国肿瘤生物治疗大会》

研究方向

肿瘤免疫

此主页由公开资料整理，尚未经学者本人认领。